PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26332145-8	2015	RESULTS: DFO remarkably enhanced expression of noted genes by mRNA and protein levels and restored activity of matrix metalloproteinases -2 and -9.	Deferoxamine	9-12	matrix metallopeptidase 2	Rattus norvegicus	111-146	
23536977-10	2013	Elevation of HIF-1alpha, upregulation of CXCR4/CCR2 and higher activity of MMP-2/MMP-9 in DFO-treated MSCs were reversed by 2-methoxyestradiol (2-ME; 5 mumol), a HIF-1alpha inhibitor.	Deferoxamine	90-93	matrix metallopeptidase 2	Rattus norvegicus	75-80	
19581022-6	2009	Furthermore, DFO treatment of DRG cell cultures activated neuroprotective and antioxidative programs such as matrix metallopeptidase 2 and apolipoprotein D to promote neurite regeneration.	Deferoxamine	13-16	matrix metallopeptidase 2	Rattus norvegicus	109-134